Related Experiment Video
Updated: Jan 20, 2026

Bioluminescent Optogenetics 2.0: Harnessing Bioluminescence to Activate Photosensory Proteins In Vitro and In Vivo
Published on: August 4, 2021
Aptamer-based protein detection using a bioluminescent fusion protein
Farhima Akter1, Masayasu Mie, Eiry Kobatake
1Department of Biological Information, Graduate School of Bioscience and Biotechnology, Tokyo Institute of Technology, 4259 Nagatsuta, Midori-ku, Yokohama 226-8501, Japan.
This study presents a novel bioluminescent immunoassay for detecting human thrombin. The assay uses a fusion protein, simplifying detection and eliminating the need for labeled analytes or aptamers.
Area of Science:
- Biochemistry
- Molecular Biology
- Assay Development
Background:
- Thrombin detection is crucial for diagnosing and monitoring various hemostatic and thrombotic disorders.
- Existing detection methods often require labeled analytes or aptamers, increasing complexity and cost.
- Development of simpler, cost-effective, and sensitive detection strategies is needed.
Purpose of the Study:
- To develop a novel aptamer-based bioluminescent immunoassay for human thrombin detection.
- To utilize a fusion protein combining Escherichia coli single-stranded DNA binding protein (SSB) and firefly luciferase (fLuc) as a detection probe.
- To demonstrate the feasibility and effectiveness of this approach for thrombin quantification.
Main Methods:
- Construction and expression of a fusion protein (SSB-fLuc) linking a thrombin aptamer to firefly luciferase via SSB.
- Purification and characterization of the fusion protein, confirming retained biological activities.
- Gel mobility shift assay to verify the binding ability of the SSB fragment with the thrombin aptamer and thrombin-thrombin aptamer complex.
- Development and validation of the bioluminescent immunoassay for thrombin detection.
Main Results:
- The SSB-fLuc fusion protein was successfully expressed and purified, with both SSB and fLuc components retaining their functions.
- The SSB fragment demonstrated specific binding to the thrombin aptamer, forming a triplex in the presence of thrombin.
- The aptamer-based bioluminescent immunoassay detected human thrombin in the nanomolar range.
- The assay proved to be simple, cost-effective, and did not require labeling of analytes or aptamers.
Conclusions:
- A novel and efficient aptamer-based bioluminescent immunoassay for human thrombin detection has been successfully developed.
- The fusion protein strategy simplifies the assay design and eliminates the need for separate labeling steps.
- This versatile detection scheme holds potential for broader applications in detecting various biomolecular targets.
Related Concept Videos
07:19Bioluminescent Optogenetics 2.0: Harnessing Bioluminescence to Activate Photosensory Proteins In Vitro and In Vivo
09:27Generation of Fluorescent Protein Fusions in Candida Species
08:46Green Fluorescent Protein-based Expression Screening of Membrane Proteins in Escherichia coli
11:46Investigating Protein-protein Interactions in Live Cells Using Bioluminescence Resonance Energy Transfer
03:41Fluorescence Anisotropy-Based Detection of Protein-Protein Interactions
Tagging and Fusion Proteins

